Attainment of personal goals in the first year of intrathecal baclofen treatment in dyskinetic cerebral palsy: a prospective cohort study

References

• Rosenbaum P, Paneth N, Leviton A, et al. A report: the definition and classification of cerebral palsy April 2006. Dev Med Child Neurol Suppl. 2007;109(Suppl.):8–14.
   PubMedGoogle Scholar
• Graham HK, Rosenbaum P, Paneth N, et al. Cerebral palsy. Nat Rev Dis Primers. 2016;2:15082.
   PubMed Web of Science ®Google Scholar
• Himmelmann K, Uvebrant P. The panorama of cerebral palsy in Sweden part XII shows that patterns changed in the birth years 2007–2010. Acta Paediatr. 2018;107(3):462–468.
   PubMed Web of Science ®Google Scholar
• Krägeloh-Mann I, Petruch U, Weber PM. SCPE reference and training manual (R&TM); 2005. Available from: http://www.scpenetwork.eu
   Google Scholar
• Monbaliu E, Himmelman K, Lin JP, et al. Clinical presentation and management of dyskinetic cerebral palsy. Lancet Neurol. 2017;16(9):741–749.
   PubMed Web of Science ®Google Scholar
• Himmelmann K, Hagberg G, Wiklund LM, et al. Dyskinetic cerebral palsy: a population-based study of children born between 1991 and 1998. Dev Med Child Neurol. 2007;49(4):246–251.
   PubMed Web of Science ®Google Scholar
• Himmelmann K, McManus V, Hagberg G, et al. Dyskinetic cerebral palsy in Europe: trends in prevalence and severity. Arch Dis Child. 2009;94(12):921–926.
   PubMed Web of Science ®Google Scholar
• Bonouvrie LA, Becher JG, Vles JSH, et al. The effect of Intrathecal baclofen in DYSkinetic cerebral palsy: the IDYS trial. Ann Neurol. 2019;86(1):79–90.
   PubMed Web of Science ®Google Scholar
• Campbell WM, McLaughlin JF, Grant GA, et al. Long-term safety and efficacy of continuous intrathecal baclofen. Dev Med Child Neurol. 2007;44(10):660–665.
   Google Scholar
• Liew PY, Stewart K, Khan D, et al. Intrathecal baclofen therapy in children: an analysis of individualized goals. Dev Med Child Neurol. 2018;60(4):367–373.
   PubMed Web of Science ®Google Scholar
• Fehlings D, Brown L, Harvey A, et al. Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review. Dev Med Child Neurol. 2018;60(4):356–366.
   PubMed Web of Science ®Google Scholar
• Eliasson AC, Krumlinde-Sundholm L, Rösblad B, et al. The Manual Ability Classification System (MACS) for children with cerebral palsy: scale development and evidence of validity and reliability. Dev Med Child Neurol. 2006;48(7):549–554.
   PubMed Web of Science ®Google Scholar
• Geytenbeek JJ, Mokkink LB, Knol DL, et al. Reliability and validity of the C-BiLLT: a new instrument to assess comprehension of spoken language in young children with cerebral palsy and complex communication needs. Augment Altern Commun. 2014;30(3):252–266.
   PubMed Web of Science ®Google Scholar
• Bonouvrié LA, Becher JG, Vles JSH, et al. Intrathecal baclofen treatment in dystonic cerebral palsy: a randomized clinical trial: the IDYS trial. BMC Pediatr. 2013;13:175–183.
   PubMed Web of Science ®Google Scholar
• Cioni G, Di Paoo MC, Bertuccelli B, et al. MRI findings and sensorimotor development in infants with bilateral spastic cerebral palsy. Brain Dev. 1997;19(4):245–253.
   PubMed Web of Science ®Google Scholar
• Turner-Stokes L. Goal Attainment Scaling (GAS) in rehabilitation: a practical guide. Clin Rehabil. 2009;23(4):362–370.
   PubMed Web of Science ®Google Scholar
• Kakooza-Mwesige A, Andrews C, Peterson S, et al. Prevalence of cerebral palsy in Uganda: a population-based study. Lancet Glob Health. 2017;5(12):e1275–e1282.
   PubMed Web of Science ®Google Scholar
• Barry MJ, VanSwearingen JM, Albright AL. Reliability and responsiveness of the Barry-Albright Dystonia Scale. Dev Med Child Neurol. 1999;41(6):404–411.
   PubMed Web of Science ®Google Scholar
• Monbaliu E, Ortibus E, de Cat J, et al. The Dyskinesia Impairment Scale: a new instrument to measure dystonia and choreoathetosis in dyskinetic cerebral palsy. Dev Med Child Neurol. 2012;54(3):278–283.
   PubMed Web of Science ®Google Scholar
• Becher JG, Doorenbosch CA, Folmer K, et al. Handbook standard physical examination in children with Central motor paresis [Handleiding standaard lichamelijk onderzoek bij kinderen met een centraal motorische parese] (Dutch). Houten: Springer Media B.V.; 2011.
   Google Scholar
• Scholtes VA, Dallmeijer AJ, Becher JG. The spasticity test: a clinical instrument to measure spasticity in children with cerebral palsy. The effectiveness of multilevel botulinum toxin type A and comprehensive rehabilitation in children with cerebral palsy. Amsterdam (The Netherlands): VU University Medical Center; 2007. p. 65–86.
   Google Scholar
• Hoving MA, van Kranen-Mastenbroek VHJM, van Raak EPM, et al. Placebo controlled utility and feasibility study of the H-reflex and flexor reflex in spastic children treated with intrathecal baclofen. Clin Neurophysiol. 2006;117(7):1508–1517.
   PubMed Web of Science ®Google Scholar
• Feldman AB, Haley SM, Coryell J. Concurrent and construct validity of the Pediatric Evaluation of Disability Inventory. Phys Ther. 1990;70(10):602–610.
   PubMed Web of Science ®Google Scholar
• Chervin RD, Weatherly RA, Garetz SL, et al. Pediatric Sleep Questionnaire: prediction of sleep apnea and outcomes. Arch Otolaryngol Head Neck Surg. 2007;133(3):216–222.
   PubMedGoogle Scholar
• Albright AL, Barry MJ, Shagron DH, et al. Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol. 2001;43:652–657.
   PubMed Web of Science ®Google Scholar
• Bonouvrie L, Becher J, Soudant D, et al. The effect of intrathecal baclofen treatment on activities of daily life in children and young adults with cerebral palsy and progressive neurological disorders. Eur J Paediatr Neurol. 2016;20(4):538–544.
   PubMed Web of Science ®Google Scholar
• Motta F, Stignani C, Antonello CE. Effects of intrathecal baclofen on dystonia in children with cerebral palsy and the use of functional scales. J Pediatr Orthop. 2008;28:213–217.
   PubMed Web of Science ®Google Scholar
• Woon K, Tsegaye M, Vloeberghs M. The role of intrathecal baclofen in the management of primary and secondary dystonia in children. Br J Neurosurg. 2007;21(4):355–358.
   PubMed Web of Science ®Google Scholar
• Tedroff K, Gyllensvärd M, Löwing K. Prevalence, identification, and interference of pain in young children with cerebral palsy: a population-based study. Disabil Rehabil. 2019;43(9):1292–1298.
   PubMed Web of Science ®Google Scholar
• Penner M, Xie WY, Binepal N, et al. Characteristics of pain in children and youth with cerebral palsy. Pediatrics. 2013;132(2):e407–e413.
   PubMed Web of Science ®Google Scholar
• McKinnon CT, Meehan EM, Harvey AR, et al. Prevalence and characteristics of pain in children and young adults with cerebral palsy: a systematic review. Dev Med Child Neurol. 2019;61(3):305–314.
   PubMed Web of Science ®Google Scholar
• Westbom L, Rimstedt A, Nordmark E. Assessments of pain in children and adolescents with cerebral palsy: a retrospective population-based registry study. Dev Med Child Neurol. 2017;59(8):858–869.
   PubMed Web of Science ®Google Scholar
• Motta F, Buonaguro V, Stignani C. The use of intrathecal baclofen pump implants in children and adolescents: safety and complications in 200 consecutive cases. J Neurosurg. 2007;107(1 Suppl.):32–35.
   PubMed Web of Science ®Google Scholar
• Ward A, Hayden S, Dexter M, et al. Continuous intrathecal baclofen for children with spasticity and/or dystonia: goal attainment and complications associated with treatment. J Paediatr Child Health. 2009;45:720–726.
   PubMed Web of Science ®Google Scholar
• Murphy NA, Nicole Irwin MC, Hoff C. Intrathecal baclofen therapy in children with cerebral palsy: efficacy and complications. Arch Phys Med Rehabil. 2002;83:1721–1725.
   PubMed Web of Science ®Google Scholar
• Jesus A, Stevenson RD. Optimizing nutrition and bone health in children with cerebral palsy. Phys Med Rehabil Clin N Am. 2020;31(1):25–37.
   PubMed Web of Science ®Google Scholar